DK187286A - Herpes-virus-specifikke immunologiske materialer og metoder - Google Patents

Herpes-virus-specifikke immunologiske materialer og metoder Download PDF

Info

Publication number
DK187286A
DK187286A DK187286A DK187286A DK187286A DK 187286 A DK187286 A DK 187286A DK 187286 A DK187286 A DK 187286A DK 187286 A DK187286 A DK 187286A DK 187286 A DK187286 A DK 187286A
Authority
DK
Denmark
Prior art keywords
hsv
residues
naturally occurring
produced
related compounds
Prior art date
Application number
DK187286A
Other languages
Danish (da)
English (en)
Other versions
DK187286D0 (da
DK166732B1 (da
Inventor
Gary H Cohen
Roselyn J Eisenberg
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of DK187286D0 publication Critical patent/DK187286D0/da
Publication of DK187286A publication Critical patent/DK187286A/da
Application granted granted Critical
Publication of DK166732B1 publication Critical patent/DK166732B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

3
DK187286A 1984-08-24 1986-04-23 Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d. DK166732B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US64420584A 1984-08-24 1984-08-24
US64420584 1984-08-24
US06/696,582 US4745182A (en) 1984-08-24 1985-01-31 Herpes virus specific immunological materials and methods
US69658285 1985-01-31
US8501481 1985-08-05
PCT/US1985/001481 WO1986001517A1 (en) 1984-08-24 1985-08-05 Herpes virus specific immunological materials and methods

Publications (3)

Publication Number Publication Date
DK187286D0 DK187286D0 (da) 1986-04-23
DK187286A true DK187286A (da) 1986-04-23
DK166732B1 DK166732B1 (da) 1993-07-05

Family

ID=27094428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK187286A DK166732B1 (da) 1984-08-24 1986-04-23 Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d.

Country Status (20)

Country Link
US (1) US4745182A (af)
EP (1) EP0172471B1 (af)
JP (2) JP2559366B2 (af)
KR (1) KR910002552B1 (af)
AT (1) ATE72267T1 (af)
AU (1) AU592064B2 (af)
CA (1) CA1254161A (af)
DE (1) DE3585306D1 (af)
DK (1) DK166732B1 (af)
ES (1) ES8607562A1 (af)
FI (1) FI102838B (af)
GR (1) GR852018B (af)
HU (1) HU195247B (af)
IE (1) IE59461B1 (af)
IL (1) IL76013A (af)
NO (1) NO170025C (af)
NZ (1) NZ213016A (af)
PH (1) PH21407A (af)
PL (1) PL150778B1 (af)
WO (1) WO1986001517A1 (af)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038933A2 (en) 2009-10-01 2011-04-07 Universität Duisburg-Essen Anti-hsv antibody

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
US5250410A (en) * 1987-01-27 1993-10-05 Allegheny-Singer Research Institute Rapid detection of herpes virus with lectin
US5646041A (en) * 1987-02-12 1997-07-08 Harfeldt; Elisabeth Monoclonal antibody to herpes simplex virus and cell line producing same
WO1990001324A1 (en) * 1988-08-10 1990-02-22 Stephen Leslie Sacks PRODUCTION OF RADIOIODINATED 1-β-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL, AND USES THEREOF, AND RELATED ANALOGUES INCORPORATING ALTERNATIVE HALOGEN RADIONUCLIDES, THE GENERAL RADIOHALOGENATION PRECURSORS, 1-(2,3,5-TRI-O-ACETYL-β-D-ARABINOFURANOSYL)-5(Z and E)-(2-TRIMETHYLSILYLVINYL)URACIL, PROCESSES FOR RADIOHA
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
EP0529057B1 (en) * 1991-03-06 1997-07-16 Ortho Diagnostic Systems Inc. Denatured vehicular proteins to improve enzyme linked immunosorbent assays
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US7267940B2 (en) * 2003-03-04 2007-09-11 Bio-Rad Laboratories, Inc. HSV-2 type-specific immunoassays using glycoprotein G2 peptides
US8252906B2 (en) 2009-01-05 2012-08-28 Dcb-Usa Llc Anti-herpes simplex virus antibodies and methods of use thereof
WO2010087813A1 (en) * 2009-01-05 2010-08-05 Dcb-Usa Llc Anti-herpes simplex virus antibodies
EP2694542A4 (en) * 2011-04-08 2014-10-08 Univ Duke HERPES SIMPLEX VIRUS
WO2024117057A1 (ja) * 2022-11-28 2024-06-06 マルホ株式会社 抗体またはその抗原結合性断片、およびこれを用いた免疫学的測定装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430437A (en) * 1980-08-27 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
US4572896A (en) * 1980-08-27 1986-02-25 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies to herpes simplex virus type I polypeptides
US4535057A (en) * 1982-07-26 1985-08-13 Amf Incorporated Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
CA1240937A (en) * 1982-07-26 1988-08-23 Gordon R. Dreesman Monoclonal igm antibodies and method of preparation
US4618570A (en) * 1984-03-27 1986-10-21 Konishiroku Photo Industry Co., Ltd. Silver halide photographic materials

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038933A2 (en) 2009-10-01 2011-04-07 Universität Duisburg-Essen Anti-hsv antibody
EP2308895A1 (en) 2009-10-01 2011-04-13 Universität Duisburg-Essen Anti-HSV antibody
US8889137B2 (en) 2009-10-01 2014-11-18 Universität Duisberg Essen Anti-HSV antibody
US9657088B2 (en) 2009-10-01 2017-05-23 Heidelberg Immunotherapeutics Gmbh Anti-HSV antibody
EP3539983A1 (en) 2009-10-01 2019-09-18 Heidelberg ImmunoTherapeutics GmbH Anti-hsv antibody

Also Published As

Publication number Publication date
AU4725885A (en) 1986-03-24
DK187286D0 (da) 1986-04-23
NO861597L (no) 1986-04-23
NO170025B (no) 1992-05-25
FI861708A0 (fi) 1986-04-23
IE852072L (en) 1986-02-24
DE3585306D1 (de) 1992-03-12
PL150778B1 (en) 1990-06-30
EP0172471A3 (en) 1988-05-18
ATE72267T1 (de) 1992-02-15
CA1254161A (en) 1989-05-16
IL76013A (en) 1990-04-29
JP2574992B2 (ja) 1997-01-22
AU592064B2 (en) 1990-01-04
WO1986001517A1 (en) 1986-03-13
US4745182A (en) 1988-05-17
JP2559366B2 (ja) 1996-12-04
GR852018B (af) 1985-12-24
ES546354A0 (es) 1986-06-16
ES8607562A1 (es) 1986-06-16
DK166732B1 (da) 1993-07-05
HUT40693A (en) 1987-01-28
EP0172471A2 (en) 1986-02-26
IL76013A0 (en) 1985-12-31
JPH06225759A (ja) 1994-08-16
NZ213016A (en) 1989-07-27
KR860005829A (ko) 1986-08-13
JPS62500032A (ja) 1987-01-08
KR910002552B1 (ko) 1991-04-24
FI102838B1 (fi) 1999-02-26
PH21407A (en) 1987-10-15
HU195247B (en) 1988-04-28
PL255119A1 (en) 1987-07-27
EP0172471B1 (en) 1992-01-29
FI102838B (fi) 1999-02-26
NO170025C (no) 1992-09-02
FI861708A (fi) 1986-04-23
IE59461B1 (en) 1994-02-23

Similar Documents

Publication Publication Date Title
DK187286A (da) Herpes-virus-specifikke immunologiske materialer og metoder
US4879213A (en) Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
CA1292839C (en) Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
EP0379949A3 (de) Verfahren zur Bestimmung von HIV-Antikörpern
AU564620B2 (en) Peptides and protein-peptide complexes
DE59209942D1 (de) HCMV-spezifische Peptide und ihre Verwendung
ES2109225T3 (es) Anticuerpos, su produccion y uso.
EP0504388A4 (en) Varicella-zoster virus antigen
EP0754755A3 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
La Thangue et al. The characterization and purification of DNA binding proteins present within herpes simplex virus infected cells using monoclonal antibodies
EP0687308A4 (en) RECOMBINANT CAPSIDANTIGENT OF THE EPSTEIN-BARR VIRUSES, WHICH IS USEFUL IN A DIAGNOSTIC METHOD
DE59814427D1 (de) Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)
Kühn et al. The use of Western blot procedures in the analysis of herpes simplex virus proteins
IT1250367B (it) Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.
Boriskin et al. Epitope analysis of mumps virus proteins in a persistent cell culture infection: changes in the hemagglutinin-neuraminidase polypeptide

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK